Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
TANG CAPITAL MANAGEMENT, LLC PYXS Pyxis Oncology, Inc. 13G/A 0% 2y
ARMISTICE CAPITAL, LLC CDAK Codiak BioSciences, Inc. Common Stock 13G/A 6.75% 2y
ARMISTICE CAPITAL, LLC SPCB SuperCom Ltd 13G 0% 2y
Sculptor Capital LP BEEP Mobile Infrastructure Corp 13G/A 0% 2y
BROWN CAPITAL MANAGEMENT LLC CYRX Cryoport, Inc. 13G/A 13.79% 2y
Black Knight, Inc. DNB Dun & Bradstreet Holdings, Inc. 13G/A 0% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC KYCH Keyarch Acquisition Corporation Ordinary Shares 13G 6.67% 2y
Pinegrove Venture Partners, LLC ROOT Root, Inc. 13G 8.2% 2y
AQR CAPITAL MANAGEMENT LLC SCRM Screaming Eagle Acquisition Corp. Class A Ordinary Shares 13G/A 3.36% 2y
FREDERIC H. MOLL SSII SS Innovations International, Inc. 13G 6.1% 2y
ROLLINS CAPITAL PARTNERS LP SOHON Sotherly Hotels Inc. 13G/A 7.1% 2y
T. Rowe Price Investment Management, Inc. RPC Ridgepost Capital, Inc. 13G/A 10.3% 2y
EVENTIDE ASSET MANAGEMENT, LLC MASS 908 Devices Inc. 13G/A 4.42% 2y
PRICE T ROWE ASSOCIATES INC /MD/ WAB Westinghouse Air Brake Technologies Corp 13G 5% 2y
Deep Track Capital, LP RPTX Repare Therapeutics Inc. Common Shares 13G/A 7.1% 2y
Phoenix Financial Ltd. ENLT Enlight Renewable Energy Ltd. 13G 11.11% 2y
RA CAPITAL MANAGEMENT, L.P. CVAC CureVac N.V. Ordinary Shares 13G/A 1.2% 2y
Christopher Diorio, Ph.D. PI Impinj Inc 13G/A 4.6% 2y
Point72 Asset Management, L.P. CRNX Crinetics Pharmaceuticals, Inc. 13G/A 5.1% 2y
OSTERWEIS CAPITAL MANAGEMENT INC DSKE Daseke, Inc. Common Stock 13G/A 7.79% 2y
Pfizer Inc EFTR eFFECTOR Therapeutics, Inc. Common Stock 13G/A 3.47% 2y
Two Seas Capital LP OMEX Odyssey Marine Exploration Inc 13G/A 9.99% 2y
Walleye Capital LLC LCW Learn CW Investment Corporation Class A Ordinary Shares 13G 5.03% 2y
T. Rowe Price Investment Management, Inc. WRBY Warby Parker Inc. 13G/A 5.2% 2y
AMERIPRISE FINANCIAL INC SYNA SYNAPTICS Inc 13G/A 10.42% 2y
M3 Funds, LLC PVBC Provident Bancorp, Inc. (MD) Common Stock 13G/A 8.67% 2y
Harvey Partners, LLC HBIO Harvard Bioscience Inc 13G/A 6% 2y
TENOR CAPITAL MANAGEMENT Co., L.P. SAMA Schultze Special Purpose Acquisition Corp. II Class A Common Stock 13G/A 0% 2y
Lumen Technologies, Inc. CYXT Cyxtera Technologies, Inc. Class A Common Stock 13G/A 0% 2y
PRICE T ROWE ASSOCIATES INC /MD/ PLRX Pliant Therapeutics, Inc. 13G 6.3% 2y
GERSHOWITZ DIANE M MCS Marcus Corp 13G 11.3% 2y
Rock Springs Capital Management LP SPRB Spruce Biosciences, Inc. 13G/A 6.41% 2y
ARMISTICE CAPITAL, LLC MURA Mural Oncology plc Ordinary Shares 13G 9.93% 2y
Fairmount Funds Management LLC TRVI Trevi Therapeutics, Inc. 13G/A 0% 2y
ALLIANCEBERNSTEIN L.P. GO Grocery Outlet Holding Corp. 13G/A 5.2% 2y
FIR TREE CAPITAL MANAGEMENT LP LIBY Liberty Resources Acquisition Corp. Class A Common Stock 13G 8.57% 2y
T. Rowe Price Investment Management, Inc. RRC Range Resources Corp 13G 6.7% 2y
Nantahala Capital Management, LLC AVTX Avalo Therapeutics, Inc. 13G/A 4.9% 2y
Rathna Girish Mathrubootham FRSH Freshworks Inc. 13G/A 6% 2y
T. Rowe Price Investment Management, Inc. GDOT Green Dot Corp 13G 7.5% 2y
Oaktree Capital Holdings, LLC NMIH NMI Holdings, Inc. 13G/A 5.8% 2y
Westchester Capital Management, LLC MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares 13G 8.97% 2y
Ayrton Capital LLC PAVM PAVmed Inc. 13G 9.9% 2y
GLAZER CAPITAL, LLC ROSS Ross Acquisition Corp II 13G/A 9.77% 2y
AQR CAPITAL MANAGEMENT LLC CETU Cetus Capital Acquisition Corp. Class A Common Stock 13G 6.17% 2y
Westchester Capital Management, LLC LCW Learn CW Investment Corporation Class A Ordinary Shares 13G 9.93% 2y
ALLIANCEBERNSTEIN L.P. GT Goodyear Tire & Rubber Co 13G/A 3.3% 2y
HGC Investment Management Inc. NETD Nabors Energy Transition Corp. II Class A Ordinary Shares 13G 8.86% 2y
HARRIS ASSOCIATES L P APA APA Corp 13G 5.12% 2y
PRICE T ROWE ASSOCIATES INC /MD/ LEGN Legend Biotech Corp 13G 5.9% 2y